Suppression of PAX6 promotes cell proliferation and inhibits apoptosis in human retinoblastoma cells

Meng,Bo; Wang,Yisong; Li,Bin

doi:10.3892/ijmm.2014.1812

Suppression of PAX6 promotes cell proliferation and inhibits apoptosis in human retinoblastoma cells

Authors:
- Bo Meng
- Yisong Wang
- Bin Li
View Affiliations

Affiliations: Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing 100005, P.R. China, Department of Microbiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, P.R. China
Published online on: June 17, 2014 https://doi.org/10.3892/ijmm.2014.1812
Pages: 399-408
Copyright: © Meng et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the role of the transcription factor, PAX6, in the development of retinoblastoma. The expression of endogenous PAX6 was knocked down using PAX6-specific lentivirus in two human retinoblastoma cell lines, SO-Rb50 and Y79. Cell proliferation functional assays and apoptotic assays were performed on the cells in which PAX6 was knocked down. The results revealed that PAX6 knockdown efficiency was significant (P<0.01, n=3) in the SO-Rb50 and Y79 cells. The inhibition of PAX6 reduced tumor cell apoptosis (P<0.05, n=3), but induced cell cycle S phase arrest (SO-Rb50; P<0.05, n=3) and G2/M phase arrest (Y79; P<0.05, n=3). Western blot analysis indicated that the inhibition of PAX6 increased the levels of the anti-apoptotic proteins, Bcl-2, proliferating cell nuclear antigen (PCNA) and CDK1, but reduced the levels of the pro-apoptotic proteins, BAX and p21. In conclusion, our data demonstrate that the suppression of PAX6 increases proliferation and decreases apoptosis in human retinoblastoma cells by regulating several cell cycle and apoptosis biomarkers.

View Figures

View References

1	Jordan T, Hanson I, Zaletayev D, et al: The human PAX6 gene is mutated in two patients with aniridia. Nat Genet. 1:328–332. 1992. View Article : Google Scholar : PubMed/NCBI
2	Quiring R, Walldorf U, Kloter U and Gehring WJ: Homology of the eyeless gene of Drosophila to the small eye gene in mice and aniridia in humans. Science. 265:785–789. 1994.PubMed/NCBI
3	Kogawa M, Hisatake K, Atkins GJ, et al: The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation. J Biol Chem. 288:31299–31312. 2013. View Article : Google Scholar
4	Hart AW, Mella S, Mendrychowski J, van Heyningen V and Kleinjan DA: The developmental regulator Pax6 is essential for maintenance of islet cell function in the adult mouse pancreas. PLoS One. 8:e541732013. View Article : Google Scholar : PubMed/NCBI
5	Hsieh YW and Yang XJ: Dynamic Pax6 expression during the neurogenic cell cycle influences proliferation and cell fate choices of retinal progenitors. Neural Dev. 4:322009. View Article : Google Scholar : PubMed/NCBI
6	Livesey FJ and Cepko CL: Vertebrate neural cell-fate determination: lessons from the retina. Nat Rev Neurosci. 2:109–118. 2001. View Article : Google Scholar : PubMed/NCBI
7	Shaham O, Menuchin Y, Farhy C and Ashery-Padan R: Pax6: a multi-level regulator of ocular development. Prog Retin Eye Res. 31:351–376. 2012. View Article : Google Scholar : PubMed/NCBI
8	Marquardt T, Ashery-Padan R, Andrejewski N, Scardigli R, Guillemot F and Gruss P: Pax6 is required for the multipotent state of retinal progenitor cells. Cell. 105:43–55. 2001. View Article : Google Scholar
9	Maulbecker CC and Gruss P: The oncogenic potential of Pax genes. EMBO J. 12:2361–2367. 1993.PubMed/NCBI
10	Sachdeva UM and O’Brien JM: Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma. J Clin Invest. 122:425–434. 2012. View Article : Google Scholar : PubMed/NCBI
11	Xu XL, Fang Y, Lee TC, et al: Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling. Cell. 137:1018–1031. 2009. View Article : Google Scholar : PubMed/NCBI
12	Cvekl A, Yang Y, Chauhan BK and Cveklova K: Regulation of gene expression by Pax6 in ocular cells: a case of tissue-preferred expression of crystallins in lens. Int J Dev Biol. 48:829–844. 2004. View Article : Google Scholar : PubMed/NCBI
13	Schedl A, Ross A, Lee M, et al: Influence of PAX6 gene dosage on development: overexpression causes severe eye abnormalities. Cell. 86:71–82. 1996. View Article : Google Scholar : PubMed/NCBI
14	Bai SW, Li B, Zhang H, et al: Pax6 regulates proliferation and apoptosis of human retinoblastoma cells. Invest Ophthalmol Vis Sci. 52:4560–4570. 2011. View Article : Google Scholar : PubMed/NCBI
15	Li L, Li B, Zhang H, et al: Lentiviral vector-mediated PAX6 overexpression promotes growth and inhibits apoptosis of human retinoblastoma cells. Invest Ophthalmol Vis Sci. 52:8393–8400. 2011. View Article : Google Scholar : PubMed/NCBI
16	Xin GH, Zhao XH, Liu D, et al: Effect of VEGF-targeted antisense gene therapy on retinoblastoma cell line SO-RB50 in vitro and in vivo. Int J Ophthalmol. 5:440–447. 2012.PubMed/NCBI
17	Sreenivasan S, Thirumalai K and Krishnakumar S: Expression profile of genes regulated by curcumin in Y79 retinoblastoma cells. Nutr Cancer. 64:607–616. 2012. View Article : Google Scholar : PubMed/NCBI
18	Zhao B, Li B, Bai S, et al: Effects of matrine on proliferation and apoptosis of cultured retinoblastoma cells. Graefes Arch Clin Exp Ophthalmol. 250:897–905. 2012. View Article : Google Scholar : PubMed/NCBI
19	Reid TW, Albert DM, Rabson AS, et al: Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst. 53:347–360. 1974.PubMed/NCBI
20	Marconett CN, Morgenstern TJ, San Roman AK, Sundar SN, Singhal AK and Firestone GL: BZL101, a phytochemical extract from the Scutellaria barbata plant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype. Cancer Biol Ther. 10:397–405. 2010.PubMed/NCBI
21	Shi T, Mazumdar T, Devecchio J, et al: cDNA microarray gene expression profiling of hedgehog signaling pathway inhibition in human colon cancer cells. PLoS One. 5:pii: e13054. 2010.PubMed/NCBI
22	Wang T, Zhao R, Wu Y, et al: Hepatitis B virus induces G1 phase arrest by regulating cell cycle genes in HepG2.2.15 cells. Virol J. 8:2312011. View Article : Google Scholar : PubMed/NCBI
23	Johnstone RW, Ruefli AA and Lowe SW: Apoptosis: a link between cancer genetics and chemotherapy. Cell. 108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
24	Fulda S: Tumor resistance to apoptosis. Int J Cancer. 124:511–515. 2009. View Article : Google Scholar
25	Kashiwagi Y, Kato N, Sassa T, et al: Cotylenin A inhibits cell proliferation and induces apoptosis and PAX6 mRNA transcripts in retinoblastoma cell lines. Mol Vis. 16:970–982. 2010.PubMed/NCBI
26	Ouyang J, Shen YC, Yeh LK, et al: Pax6 overexpression suppresses cell proliferation and retards the cell cycle in corneal epithelial cells. Invest Ophthalmol Vis Sci. 47:2397–2407. 2006. View Article : Google Scholar : PubMed/NCBI
27	Zhang X, Huang CT, Chen J, et al: Pax6 is a human neuroectoderm cell fate determinant. Cell Stem Cell. 7:90–100. 2010. View Article : Google Scholar : PubMed/NCBI
28	Davis N, Yoffe C, Raviv S, et al: Pax6 dosage requirements in iris and ciliary body differentiation. Dev Biol. 333:132–142. 2009. View Article : Google Scholar : PubMed/NCBI
29	Estivill-Torrus G, Pearson H, van Heyningen V, Price DJ and Rashbass P: Pax6 is required to regulate the cell cycle and the rate of progression from symmetrical to asymmetrical division in mammalian cortical progenitors. Development. 129:455–466. 2002.PubMed/NCBI
30	Gotz M, Stoykova A and Gruss P: Pax6 controls radial glia differentiation in the cerebral cortex. Neuron. 21:1031–1044. 1998. View Article : Google Scholar : PubMed/NCBI
31	Warren N, Caric D, Pratt T, et al: The transcription factor, Pax6, is required for cell proliferation and differentiation in the developing cerebral cortex. Cereb Cortex. 9:627–635. 1999. View Article : Google Scholar : PubMed/NCBI
32	Berger J, Berger S, Tuoc TC, et al: Conditional activation of Pax6 in the developing cortex of transgenic mice causes progenitor apoptosis. Development. 134:1311–1322. 2007. View Article : Google Scholar : PubMed/NCBI
33	Duncan MK, Haynes JI II, Cvekl A and Piatigorsky J: Dual roles for Pax-6: a transcriptional repressor of lens fiber cell-specific beta-crystallin genes. Mol Cell Biol. 18:5579–5586. 1998.PubMed/NCBI
34	Grindley JC, Davidson DR and Hill RE: The role of Pax-6 in eye and nasal development. Development. 121:1433–1442. 1995.PubMed/NCBI
35	Richardson J, Cvekl A and Wistow G: Pax-6 is essential for lens-specific expression of zeta-crystallin. Proc Natl Acad Sci USA. 92:4676–4680. 1995. View Article : Google Scholar : PubMed/NCBI
36	Walther C and Gruss P: Pax-6, a murine paired box gene, is expressed in the developing CNS. Development. 113:1435–1449. 1991.PubMed/NCBI
37	Zhang W, Cveklova K, Oppermann B, Kantorow M and Cvekl A: Quantitation of PAX6 and PAX6(5a) transcript levels in adult human lens, cornea, and monkey retina. Mol Vis. 7:1–5. 2001.
38	Yamaoka T, Yano M, Yamada T, Matsushita T, Moritani M, Ii S, Yoshimoto K, Hata J and Itakura M: Diabetes and pancreatic tumours in transgenic mice expressing Pax6. Diabetologia. 43:332–339. 2000. View Article : Google Scholar : PubMed/NCBI
39	Kleinjan DA, Seawright A, Mella S, et al: Long-range downstream enhancers are essential for Pax6 expression. Dev Biol. 299:563–581. 2006. View Article : Google Scholar
40	Zhang J, Lu JP, Suter DM, et al: Isoform- and dose-sensitive feedback interactions between paired box 6 gene and delta-catenin in cell differentiation and death. Exp Cell Res. 316:1070–1081. 2010. View Article : Google Scholar : PubMed/NCBI
41	Duparc RH, Abdouh M, David J, Lepine M, Tetreault N and Bernier G: Pax6 controls the proliferation rate of neuroepithelial progenitors from the mouse optic vesicle. Dev Biol. 301:374–387. 2007. View Article : Google Scholar : PubMed/NCBI
42	Haubst N, Berger J, Radjendirane V, et al: Molecular dissection of Pax6 function: the specific roles of the paired domain and homeodomain in brain development. Development. 131:6131–6140. 2004. View Article : Google Scholar : PubMed/NCBI
43	Shaham O, Smith AN, Robinson ML, Taketo MM, Lang RA and Ashery-Padan R: Pax6 is essential for lens fiber cell differentiation. Development. 136:2567–2578. 2009. View Article : Google Scholar : PubMed/NCBI
44	Cayrol C, Knibiehler M and Ducommun B: p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene. 16:311–320. 1998. View Article : Google Scholar : PubMed/NCBI
45	Frouin I, Maga G, Denegri M, et al: Human proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1/cip1. A dynamic exchange of partners. J Biol Chem. 278:39265–39268. 2003. View Article : Google Scholar : PubMed/NCBI
46	Bunz F, Dutriaux A, Lengauer C, et al: Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 282:1497–1501. 1998. View Article : Google Scholar : PubMed/NCBI
47	Møller MB: P27 in cell cycle control and cancer. Leuk Lymphoma. 39:19–27. 2000.
48	Taylor WR and Stark GR: Regulation of the G2/M transition by p53. Oncogene. 20:1803–1815. 2001. View Article : Google Scholar : PubMed/NCBI